A drug for pulmonary fibrosis created using artificial intelligence is showing early promise in patients. Its progress highlights how AI is remaking one of the slowest, costliest areas of science. (more…)
In the era of AI-generated news, readers value trust over customised content
The future of AI in journalism will depend on a balance between benefits and risk, and raising audience comfort, trust and news literacy.
